Immunotherapy, AdoptiveImmunotherapyImmunotherapy, ActiveDesensitization, ImmunologicCancer VaccinesAntineoplastic Combined Chemotherapy ProtocolsAntigens, NeoplasmT-Lymphocytes, CytotoxicLymphocytes, Tumor-InfiltratingInterleukin-2Cytokine-Induced Killer CellsT-LymphocytesNeoplasmsImmunization, PassiveCytotoxicity, ImmunologicMelanoma, ExperimentalCD8-Positive T-LymphocytesCombined Modality TherapyKiller Cells, Lymphokine-ActivatedMelanomaLymphocyte ActivationChemotherapy, AdjuvantCell Line, TumorAntineoplastic AgentsMice, Inbred C57BLFibrosarcomaDendritic CellsAntibodies, MonoclonalHLA-A2 AntigenNeoplasm TransplantationLung NeoplasmsPicibanilArtificial CellsTreatment OutcomeInterferon-gammaHLA-A24 AntigenAdministration, SublingualNeoplasms, ExperimentalLymphocyte TransfusionMice, Inbred BALB CTumor EscapeSarcoma, ExperimentalCyclophosphamideTumor Cells, CulturedKiller Cells, NaturalAdoptive TransferCD4-Positive T-LymphocytesSublingual ImmunotherapyFlow Cytometrygp100 Melanoma AntigenAntigens, CD3Xenograft Model Antitumor AssaysEpitopes, T-LymphocyteReceptors, Antigen, T-CellRhinitis, Allergic, SeasonalMuromonab-CD3Neoplasm MetastasisMice, SCIDNeoplasm ProteinsMART-1 AntigenHLA-A AntigensTransduction, GeneticLymph NodesBreast NeoplasmsAllergensT-Lymphocytes, RegulatoryMelanoma-Specific AntigensCisplatinCell ProliferationKidney NeoplasmsMice, TransgenicDrug Screening Assays, AntitumorClinical Trials as TopicSurvival RateReceptors, AntigenTime FactorsGraft vs Tumor EffectTransplantation, HomologousBrain NeoplasmsGenetic VectorsK562 CellsLentinanT-Lymphocyte SubsetsCytokinesAntigen-Presenting CellsSurvival AnalysisImmunophenotypingOvarian NeoplasmsAntigen PresentationLymphocyte DepletionMice, NudeAntigens, CDRecombinant ProteinsCytotoxicity Tests, ImmunologicDoxorubicinDisease-Free SurvivalGenetic TherapyAntigens, CD28PrognosisColonic Neoplasms